BOSTON, MA—(UPDATED) Patients with severe symptomatic degenerative mitral regurgitation (MR) ineligible for surgery fare just as well when treated with the Pascal device (Edwards Lifesciences) as ...
SAN FRANCISCO, CA—For patients with symptomatic degenerative mitral regurgitation (DMR) and a prohibitive surgical risk, transcatheter edge-to-edge repair (TEER) with either of two approved devices ...
LONDON -- Despite another positive trial, controversy rages on over transcatheter edge-to-edge repair (TEER or M-TEER) in people with symptomatic heart failure (HF) and functional mitral regurgitation ...
BOSTON -- Contemporary practice had the fourth-generation MitraClip producing low short-term mortality and other good results even in mitral regurgitation (MR) patients previously deemed unsuitable ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — An analysis of the STS/ACC TVT registry showed that successful transcatheter edge-to-edge repair ...
BOSTON – September 17, 2022 – Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral ...
The overall case volume for surgical mitral-valve (MV) repair of degenerative mitral regurgitation (DMR) hasn't changed much nearly a decade into the age of transcatheter edge-to-edge repair (TEER).
The first order of business in the long-awaited, recently released Centers for Medicare and Medicaid Services (CMS) proposed national coverage decision (NCD) for transcatheter mitral valve repair ...
Results of the first randomized controlled trial to directly compare two contemporary transcatheter edge-to-edge repair (TEER) devices for degenerative mitral regurgitation (DMR) found that the PASCAL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results